Our results showed that the significant correlation between elevated APLN expression and inferior OS or RFS in LGG patients was restricted to patients with seizure history, primary tumor, targeted molecular therapy, oligodendroglioma, biopsy, and TMZ therapy. Here, APLN is linked to oligodendroglioma.